ClinicalTrials.Veeva

Find clinical trials for Endometrial Cancer in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Nashville, TN, USA:

Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. (POD1UM-204)

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Enrolling
Endometrial Cancer
Drug: INCAGN02390
Drug: pemigatinib

Phase 2

Incyte
Incyte

Nashville, Tennessee, United States and 66 other locations

Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor...

Enrolling
Endometrial Cancer
Lung Cancer
Drug: Docetaxel
Drug: Carboplatin

Phase 1

Inspirna

Nashville, Tennessee, United States and 20 other locations

Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-002 given intravenously every 3 weeks.

Enrolling
Endometrial Cancer
Ovary Cancer
Drug: STRO-002

Phase 1

Sutro Biopharma

Nashville, Tennessee, United States and 26 other locations

IMGN151-1001 is a Phase 1, first in human, open-label dose-escalation and expansion study in adult patients with recurrent endometrial cancer...

Enrolling
Endometrial Cancer
Fallopian Tube Cancer
Drug: IMGN151

Phase 1

ImmunoGen
ImmunoGen

Nashville, Tennessee, United States and 5 other locations

for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...

Active, not recruiting
Endometrial Cancer
Drug: Matching placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Nashville, Tennessee, United States and 76 other locations

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

Nashville, Tennessee, United States and 75 other locations

This is a Phase 1 dose-escalation study of PRT3645, a Cyclin-dependent Kinase 4/6 (CDK4/6) inhibitor, in patients with advanced or metastatic solid t...

Active, not recruiting
Endometrial Cancer
Non-small Cell Lung Cancers
Drug: PRT3645

Phase 1

Prelude Therapeutics

Nashville, Tennessee, United States and 12 other locations

in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...

Enrolling
Endometrial Cancer
Non-small Cell Lung Cancer
Drug: PRO1184 intravenous infusion of PRO1184
Drug: PRO1184

Phase 1, Phase 2

ProfoundBio

Nashville, Tennessee, United States and 21 other locations

antigen (HLA) and MAGE-A4 tumor antigen. Tumor indications include endometrial, esophageal, esophagogastric junction (EGJ), gastric, head an....

Enrolling
Endometrial Cancer
Esophageal Cancer
Genetic: Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks

Phase 1

Adaptimmune

Nashville, Tennessee, United States and 21 other locations

Phase.Cohort A: Advanced or Metastatic Triple Negative Breast Cancer (TNBC) (IO-treated)Cohort B: Advanced or Metastatic Triple Negative Bre ...

Active, not recruiting
Endometrial Cancer
Triple Negative Breast Cancer
Drug: Fruquintinib
Drug: Tislelizumab

Phase 1, Phase 2

HUTCHMED
HUTCHMED

Nashville, Tennessee, United States and 15 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems